Augmentative effects of PoweFill
Not Applicable
Completed
- Conditions
- Diseases of The genitoruinary system
- Registration Number
- KCT0001827
- Lead Sponsor
- REGEN Biotech
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 23
Inclusion Criteria
(1) healthy men, aged 20 to 65
(2) men with small penis syndrome
(3) during the study period, subject will not received any treatments associated with penile augmentation
(4) after 1month, subject can perform the sexual intercourse
(5) subject will agree with investigator's decision
(6) subject will sign an informed consent form
Exclusion Criteria
(1) any history of psychological or psychiatric illness,
(2) congenital or acquired penile malformation including severe phimosis,
(3) previous PA history,
(4) any chronic major systemic disease including diabetes and coagulopathy
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method increase in penile girth by 1.2cm or more
- Secondary Outcome Measures
Name Time Method subject satisfaction